Activation of MET pathway predicts poor outcome to...

Activation of MET pathway predicts poor outcome to cetuximab in patients with recurrent or metastatic head and neck cancer

Madoz-Gúrpide, Juan, Zazo, Sandra, Chamizo, Cristina, Casado, Victoria, Caramés, Cristina, Gavín, Eduardo, Cristóbal, Ion, García-Foncillas, Jesús, Rojo, Federico
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Journal of Translational Medicine
DOI:
10.1186/s12967-015-0633-7
Date:
December, 2015
File:
PDF, 1.60 MB
english, 2015
Conversion to is in progress
Conversion to is failed